Dr. Shaween Ziyad Jamil

Degree: M.B.Ch.B , MSc Cardiology, PhD , CBCCT, CBCMR
Cardiologist/ Cardiac Imaging Specialist
Other- Role: Research Coordinator

Area of Interest:
Applying advanced cardiac imaging techniques like CMR to meticulously analyzing ischemic heart disease, structural heart disease and peripheral vascular disease and utilizing these techniques for the comprehensive screening, prevention, and management of various illnesses, with a particular interest in cardiometabolic diseases.

Publications:
1-Al-Talabany ZJ.S , Ahmed M. N, Abdullah R. A, Abdullah J. Sh. Right Atrial Carcinoid Tumor With Pulmonary Embolism in A 17-year-old: A Case Report. JCCT January-February 2025.
2- Ahmed M. N , Al-Talabany ZJ.S CT Angiography Challenges and Short Term Results of Midcab Surgery. JCCT January-February 2025.

3-Al-Talabany ZJ. S, Ahmed M. N, Abdullah R. A, Abdullah J. Sh. The comparability between CTCA and ICA in detecting LAD patency to predict graftibility in CABG patient candidates. JCCT January-February 2024.

2- Nasih M. Ahmed MSc, Shaween ZJ. Al-Talabany PhD, Aras R. Abdullah MSc, Dr Shwan O. Amen PhD, Shelan J. Abdullah HD. The distributions pattern of coronary artery disease in patients with diabetes versus non diabetes. JCCT January-February 2023.

3- Nasih M. Ahmed MSc, Shaween Z.J Al-Talabany PhD. .Cardiac Hydatid cysts: A 256 MSCT cardiac CT evaluation case series reports. JCCT January-February 2023.

4- Naish .M Abdulla, Shaween Z.J Al-Talabany, Aras. R. Abdulla, Shelan J. Abdulla. Prevalence and Extent of Coronary Artery Disease among Patients with a Zero Calcium Score.2022.

5-Al-Talabany S. et al. Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes. BMC cardiovascular disorders 2018.

6- Mohan M et al. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. European heart journal 2019.

7-Al-Talabany S. et al. Effect of metformin on epicardial adipose tissue in patients with coronary artery disease without diabetes: A cardiac MRI substudy of the MET-remodel trial. Obesity Medicine 2021.

8-Al-Talabany S. et al. Epicardial adipose tissue is related to arterial stiffness in patients with cardiometabolic disease. JACC.2016.

9-Al-Talabany S. et al. Metformin and Dapagliflozin Effects On Epicardial Adipose Tissue Area In Prediabetes and Type 2 Diabetes Patients: MRI Evaluation Studies. Global Heart 2018.

10- Al-Talabany S. et al. MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients. European Heart Journal 2018.